Medtronic is the world's leading medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Primary products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company's product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.
Medtronic is the world's leading medical technology company, pioneeringdevice-based therapies that restore health, extend life and alleviate pain.Primary products include those for bradycardia pacing, tachyarrhythmiamanagement, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company's product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.
Sell - long term down-side. They are the major player in the Medical Device market, and they are huge in ortho, but the recent Infuse debacle is going to be devastating. This, combined with the company's arrogance due to their size,will result in long-term sales stagnation.
Sell - long term down-side. They are the major player in the Medical Device market, and they are huge in ortho, but the recent Infuse debacle is going to be devastating. This, combined with the company's arrogance due to their size,will result in long-term sales stagnation.
Medtronic is a global leader in implantable medical devices. The company has been flourishing under newly appointed management, which is improving efficiency and the product pipeline. In its fiscal first quarter, the company grew its revenue by 18.5% year over year, which was a quicker pace than the 17.7% rate reported in the previous quarter, despite the declining condition of the global economy. At the same time, gross margin improved to 76.9% from 74.7%. Demand is not likely to fall significantly given its position as a medical company that generally provides products that greatly benefit patients' well-being. A study released yesterday demonstrated that drug-eluting coronary stents perform materially better than normal ones; this is a major product category for Medtronic. It is also making successful inroads towards improving its position in other product categories such as chronic pain relief and glucose monitoring for diabetes patients. The stock's current price reflects excess devaluation along with the broad market, giving it ample room to appreciate. I'm looking for a move to $45 and then $50 longer term.
Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up
Ride Momentum Stocks to Quick Gains!
The market is finally breaking out, creating the perfectd wave for investing in momentum stocks. Zacks is the king of fundamental analysis, but this service also uses technical indicators for the best possible timing. Click here to learn more >>.
No Stocks are Harder to Find, or More Worth the Effort.
They have the greatest potential for quick gains, but they're also the most difficult to find and time correctly. Now Zacks has perfected a system for identifying and profiting from turnaround stocks just as they begin a powerful rebound.
Learn more here >>.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Potentially a $60 stock
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment